As of 2025-07-19, the Relative Valuation of Outlook Therapeutics Inc (OTLK) is 10.49 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.18 USD, the upside of Outlook Therapeutics Inc based on Relative Valuation is 381.3%.
The range of the Relative Valuation is 7.73 - 14.01 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 24.0x | 19.8x |
| Forward P/E multiples | 17.3x - 28.5x | 22.9x |
| Fair Price | 7.73 - 14.01 | 10.49 |
| Upside | 254.4% - 542.7% | 381.3% |
| Date | P/E |
| 2025-07-16 | 4.91 |
| 2025-07-15 | 4.62 |
| 2025-07-14 | 4.73 |
| 2025-07-11 | 4.22 |
| 2025-07-10 | 4.11 |
| 2025-07-09 | 3.97 |
| 2025-07-08 | 3.85 |
| 2025-07-07 | 3.79 |
| 2025-07-03 | 3.63 |
| 2025-07-02 | 3.48 |
| 2025-07-01 | 3.22 |
| 2025-06-30 | 3.26 |
| 2025-06-27 | 3.26 |
| 2025-06-26 | 3.56 |
| 2025-06-25 | 3.67 |
| 2025-06-24 | 3.61 |
| 2025-06-23 | 3.42 |
| 2025-06-20 | 3.47 |
| 2025-06-18 | 3.42 |
| 2025-06-17 | 3.44 |
| 2025-06-16 | 3.61 |
| 2025-06-13 | 3.71 |
| 2025-06-12 | 3.75 |
| 2025-06-11 | 3.65 |
| 2025-06-10 | 3.74 |
| 2025-06-09 | 3.87 |
| 2025-06-06 | 3.87 |
| 2025-06-05 | 3.81 |
| 2025-06-04 | 3.89 |
| 2025-06-03 | 3.77 |
| 2025-06-02 | 3.61 |
| 2025-05-30 | 3.75 |
| 2025-05-29 | 3.67 |
| 2025-05-28 | 3.32 |
| 2025-05-27 | 3.28 |
| 2025-05-23 | 3.26 |
| 2025-05-22 | 3.34 |
| 2025-05-21 | 3.32 |
| 2025-05-20 | 3.46 |
| 2025-05-19 | 3.59 |
| 2025-05-16 | 3.56 |
| 2025-05-15 | 3.41 |
| 2025-05-14 | 3.55 |
| 2025-05-13 | 4.14 |
| 2025-05-12 | 3.24 |
| 2025-05-09 | 3.12 |
| 2025-05-08 | 2.93 |
| 2025-05-07 | 2.87 |
| 2025-05-06 | 2.91 |
| 2025-05-05 | 3.16 |